phase readout
saveNCT06714370: Real-World Evidence of Effectiveness and Safety of Tirabrutinib in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma in Taiwan: A Nationwide Study
COMPLETEDupdated 15d ago
community read0 votes
Sponsor: Ono Pharmaceutical Co., Ltd.. Phase: . Conditions: Primary Central Nervous System Lymphoma (PCNSL)
view source ↗
comments(0)
5-min edit window · permanent after that